A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.
about
Ketamine and other glutamate receptor modulators for depression in adultsKetamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeuticsThe role of ketamine in treatment-resistant depression: a systematic review.Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.Current status of ketamine and related compounds for depressionSingle-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories.Failed response to repeat intravenous ketamine infusions in geriatric patients with major depressive disorder.KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE.A REVIEW OF KETAMINE ABUSE AND DIVERSION.Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction.Psychiatric morbidity in ketamine users attending counselling and youth outreach services.Anxiety-like behaviour assessments of adolescent rats after repeated maternal separation during early life.Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.Ketamine’s Mechanism of Rapid Antidepressant Activity: Evidence Gleaned from Clinical Studies
P2860
Q24186746-7050C414-5577-4849-90BF-6A5AD38C951AQ34444632-C940F441-EDFD-4E74-A1E3-E3A949CFA8F1Q34449588-4276C833-006C-4759-A11E-FDCC75FFB999Q35547495-28BF2EC9-56E0-4FCB-9B81-CDDB32DE6F84Q37202885-2FB38EAC-7006-4279-9DFF-8D4A5121226FQ37424333-8A64F941-A429-4252-A67B-E8D183BB1402Q37614804-F3719F3C-C72F-4686-8B85-C77C80E1378EQ38803429-C2EDD3E3-146E-4E68-B83C-CF31E36A5F69Q38872263-03D3B4C4-0EB8-495A-A6A3-9E8EBC46330FQ47658882-663CF3BF-9021-4C44-9943-7BB322E006DBQ47844005-A29A4D67-6663-441D-A51A-68FEB869D1C9Q52645187-61637B14-3083-4248-9281-7DD5F8CF6F87Q55438088-B0EC8014-E628-4360-8FCC-4A88839ACACCQ55535831-001C1603-7473-4AD2-A292-45900964D049Q58213893-09F14C90-AE76-4122-9B4E-DD35A7174570
P2860
A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A 12-month naturalistic observ ...... reatment-resistant depression.
@en
A 12-month naturalistic observ ...... reatment-resistant depression.
@nl
type
label
A 12-month naturalistic observ ...... reatment-resistant depression.
@en
A 12-month naturalistic observ ...... reatment-resistant depression.
@nl
prefLabel
A 12-month naturalistic observ ...... reatment-resistant depression.
@en
A 12-month naturalistic observ ...... reatment-resistant depression.
@nl
P2860
P1476
A 12-month naturalistic observ ...... treatment-resistant depression
@en
P2093
Nora Finnegan
Roman M Dale
P2860
P304
P356
10.1016/J.JAD.2012.10.015
P577
2012-11-22T00:00:00Z